Journal
Molecular Therapy Methods & Clinical Development
Publication Date
6-13-2024
Volume
32
Issue
2
First Page
101265
Document Type
Open Access Publication
DOI
10.1016/j.omtm.2024.101265
Rights and Permissions
Wang T, Navenot JM, Rafail S, Kurtis C, Carroll M, Van Kerckhoven M, Van Rossom S, Schats K, Avraam K, Broad R, Howe K, Liddle A, Clayton A, Wang R, Quinn L, Sanderson JP, McAlpine C, Carozza C, Pimpinella E, Hsu S, Brophy F, Elefant E, Bayer P, Williams D, Butler MO, Clarke JM, Gainor JF, Govindan R, Moreno V, Johnson M, Tu J, Hong DS, Blumenschein GR Jr. Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients. Mol Ther Methods Clin Dev. 2024 May 14;32(2):101265. doi: 10.1016/j.omtm.2024.101265. Copyright 2024 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Wang, Tianjiao; Govindan, Ramaswamy; and et al., "Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients." Molecular Therapy Methods & Clinical Development. 32, 2. 101265 (2024).
https://digitalcommons.wustl.edu/oa_4/5518
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
